Greater Glasgow and Clyde Medicines

Medicines Update

GGC Medicines Update is a series of blogs with important medicines related messages relevant to all healthcare professionals across GGC.

Please note, Medicines Update blogs are correct at the time of publication.

Medicines Update blogs remain on the website for 4 years. If you would like a copy of a blog published more than 4 years ago, please contact ggc.medicines.update@nhs.scot

Click here for a promotional poster on Medicines Update and here for an animation on the Communications subcommittee of ADTC responsible for the development of Medicines Update.

If you would like to contribute to Medicines Update, click here for further information and here for a guide to blog writing. When you email the committee to discuss writing a blog, you will be sent a checklist to complete prior to submitting the blog for review.

Treatment of Iron Deficiency Anaemia (IDA) - IV iron therapy

Posted: Wednesday, July 31, 2024

Category - Medicines Update

IV iron:

  • Should be reserved as a second line treatment choice in the management of IDA.*
  • Does not produce a faster Hb response than oral iron (provided that the oral iron preparation is taken reliably and is absorbed adequately).
  • Can cause hypersensitivity reactions which may be life-threatening or fatal (only administer during working hours when adequate supervision is available).
  • Paravenous leakage may lead to permanent staining at the site of infusion.

 * see inclusion criteria for IV iron therapy in full guideline, including use as first line agent in certain clinical settings.

Read More...

Treatment of Iron Deficiency Anaemia (IDA) in Adults: Oral and Intravenous Iron Therapy

Posted: Wednesday, July 31, 2024

Category - Medicines Update

  • Oral iron is the first line treatment of choice.
  • Investigations to determine the underlying cause should be considered in parallel with treatment.
  • IV iron should be reserved as a second line treatment option.*

* see inclusion criteria for IV iron therapy in full guideline, including use as first line agent in certain clinical settings.

Read More...

Polypharmacy Review in Adults Living with Moderate to Severe Frailty - Use of Psychotropic Medications in Patients with Dementia

Posted: Friday, July 12, 2024

Category - Medicines Update

Key Messages

  • Non-pharmacological approaches should be used first-line to manage stress and distress in dementia.
  • Psychotropic medications carry the risk of side effects which may cause serious avoidable harms (e.g. falls, sedation, etc) and should be used as a last resort in the management of stress and distress - other causes should be ruled out including infection, constipation, and pain.
  • If required, the lowest effective dose of psychotropic medication should be prescribed for the shortest possible period with regular review.
  • For patients under Community Mental Health Teams (CMHT) psychotropic medication changes should be made in collaboration with their CMHT.
Read More...